These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 19785760)

  • 1. The use of evidence in public governmental reports on health policy: an analysis of 17 Norwegian official reports (NOU).
    Innvaer S
    BMC Health Serv Res; 2009 Sep; 9():177. PubMed ID: 19785760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based medicine - an appropriate tool for evidence-based health policy? A case study from Norway.
    Malterud K; Bjelland AK; Elvbakken KT
    Health Res Policy Syst; 2016 Mar; 14():15. PubMed ID: 26945751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expert committees in German public health policymaking during the SARS-CoV-2 pandemic: a document analysis].
    Sell K; Saringer-Hamiti L; Geffert K; Strahwald B; Stratil JM; Pfadenhauer LM
    Z Evid Fortbild Qual Gesundhwes; 2021 Oct; 165():1-12. PubMed ID: 34474991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.
    Callaghan A; Kendall G; Lock C; Mahony A; Payne J; Verrier L
    JBI Libr Syst Rev; 2005; 3(6):1-33. PubMed ID: 27819973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].
    Amato L; Colais P; Davoli M; Ferroni E; Fusco D; Minozzi S; Moirano F; Sciattella P; Vecchi S; Ventura M; Perucci CA
    Epidemiol Prev; 2013; 37(2-3 Suppl 2):1-100. PubMed ID: 23851286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges to decision-making processes in the national HTA agency in Brazil: operational procedures, evidence use and recommendations.
    Yuba TY; Novaes HMD; de Soárez PC
    Health Res Policy Syst; 2018 May; 16(1):40. PubMed ID: 29751764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.
    Callaghan A; Kendall G; Lock C; Mahony A; Payne J; Verrier L
    Int J Evid Based Healthc; 2005 Jul; 3(6):147-67. PubMed ID: 21631747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of science in policy making--EuSANH-ISA project, framework for science advice for health].
    Cianciara D; Piotrowicz M; Bielska-Lasota M; Wysocki MJ
    Przegl Epidemiol; 2012; 66(3):521-9. PubMed ID: 23230726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding public elderly care policy in Norway: A narrative analysis of governmental White papers.
    Jacobsen FF
    J Aging Stud; 2015 Aug; 34():199-205. PubMed ID: 26162742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of economic evaluations in NHS decision-making: a review and empirical investigation.
    Williams I; McIver S; Moore D; Bryan S
    Health Technol Assess; 2008 Apr; 12(7):iii, ix-x, 1-175. PubMed ID: 18373906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Budget impact analysis-principles of good practice: report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force.
    Sullivan SD; Mauskopf JA; Augustovski F; Jaime Caro J; Lee KM; Minchin M; Orlewska E; Penna P; Rodriguez Barrios JM; Shau WY
    Value Health; 2014; 17(1):5-14. PubMed ID: 24438712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subjective judgements - no more, no less? A response to Malterud, Bjelland and Elvbakken.
    Fretheim A
    Health Res Policy Syst; 2018 Nov; 16(1):111. PubMed ID: 30458794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.
    Chilcott J; Tappenden P; Rawdin A; Johnson M; Kaltenthaler E; Paisley S; Papaioannou D; Shippam A
    Health Technol Assess; 2010 May; 14(25):iii-iv, ix-xii, 1-107. PubMed ID: 20501062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Policy Governance in the UK: lessons from changes to and debates concerning the classification of cannabis under the 1971 Misuse of Drugs Act.
    Monaghan M
    Int J Drug Policy; 2014 Sep; 25(5):1025-30. PubMed ID: 24635973
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.